Technical analysis of Dyne Therapeutics, Inc. (DYN): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs.
Price Performance
| 1 month | +9.80% |
| 3 months | -35.73% |
| Year-to-date | -14.67% |
| 1 year | -26.09% |
| 3 years | +102.79% |
| 5 years | +13.38% |
52-Week Range
| 52-week High | $27.31 |
| 52-week Low | $14.00 |
| Avg Volume (90d) | 2.7M |
Technical Indicators
| SMA 50 | $18.53 |
| SMA 200 | $19.31 |
| Beta | 1.28 |
| 30-day Volatility (annualised) | 53.0% |
| Price vs SMA 50 | -9.9% |
| Price vs SMA 200 | -13.6% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $19.56 | |
| 2026-01 | $17.89 | -8.5% |
| 2026-02 | $15.62 | -12.7% |
| 2026-03 | $18.13 | +16.1% |
| 2026-04 | $17.55 | -3.2% |
| 2026-05 | $19.33 | +10.1% |
| 2026-06 | $22.21 | +14.9% |
| 2026-07 | $25.18 | +13.4% |
| 2026-08 | $25.43 | +1.0% |
| 2026-09 | $16.11 | -36.6% |
| 2026-10 | $16.69 | +3.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2027-03-04 | $-0.92 | |
| 2026-11-04 | $-0.91 | |
| 2026-07-30 | $-0.75 | |
| 2026-05-11 | $-0.77 | |
| 2026-03-02 | $-0.74 | |
| 2025-11-05 | $-0.81 | |
| 2025-07-28 | $-0.99 | |
| 2025-05-08 | $-0.88 | |
Price
| Price | $16.69 (closing price, October 30, 2026) |
| Market Cap | $3.1B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 3.93 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.03 |
| Current Ratio | 12.02 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 5.16 |